homovanillic acid has been researched along with Brown Tendon Sheath Syndrome in 6 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the purported role of central monoamine disturbances in the pathophysiology of the opsoclonus-myoclonus syndrome, the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid were measured in cerebrospinal fluid samples from 27 affected children and 47 age- and gender-matched control subjects by high-pressure liquid chromatography with electrochemical detection." | 9.08 | Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. ( Banasiak, K; Gospe, SM; Huang, Y; Noetzel, MJ; Pranzatelli, MR; Stanley, M; Tate, E, 1995) |
| "To study the purported role of central monoamine disturbances in the pathophysiology of the opsoclonus-myoclonus syndrome, the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid were measured in cerebrospinal fluid samples from 27 affected children and 47 age- and gender-matched control subjects by high-pressure liquid chromatography with electrochemical detection." | 5.08 | Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. ( Banasiak, K; Gospe, SM; Huang, Y; Noetzel, MJ; Pranzatelli, MR; Stanley, M; Tate, E, 1995) |
| "This syndrome is usually caused by endogenous dopamine deficiency but in these patients was associated with elevated dopamine metabolites in CSF and an unusual eye movement disorder: ocular flutter together with saccade initiation failure." | 1.32 | Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF. ( Assmann, BE; Bräutigam, C; Heales, SJ; Hoffmann, GF; Hyland, K; Robinson, RO; Sharma, R; Surtees, RA; Wevers, RA; Zschocke, J, 2004) |
| "Children with the opsoclonus-myoclonus syndrome (OMS) usually respond to corticotropin (adrenocorticotrophic hormone, ACTH) treatment but the mechanism of benefit is unknown." | 1.30 | Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus. ( Goldstein, DS; Goldstein, EM; Holmes, CS; Huang, YY; Ketner, K; Kinast, M; Lange, BM; Pranzatelli, MR; Sanz, A; Shevell, MI; Stanford, RE; Taff, IP; Tate, E, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, AK | 1 |
| Bradley, K | 1 |
| Piña-Garza, JE | 1 |
| Kurian, MA | 1 |
| Li, Y | 1 |
| Zhen, J | 1 |
| Meyer, E | 1 |
| Hai, N | 1 |
| Christen, HJ | 1 |
| Hoffmann, GF | 2 |
| Jardine, P | 1 |
| von Moers, A | 1 |
| Mordekar, SR | 1 |
| O'Callaghan, F | 1 |
| Wassmer, E | 1 |
| Wraige, E | 1 |
| Dietrich, C | 1 |
| Lewis, T | 1 |
| Hyland, K | 2 |
| Heales, S | 1 |
| Sanger, T | 1 |
| Gissen, P | 1 |
| Assmann, BE | 2 |
| Reith, ME | 1 |
| Maher, ER | 1 |
| Robinson, RO | 1 |
| Surtees, RA | 1 |
| Bräutigam, C | 1 |
| Heales, SJ | 1 |
| Wevers, RA | 1 |
| Zschocke, J | 1 |
| Sharma, R | 1 |
| Koh, PS | 1 |
| Raffensperger, JG | 1 |
| Berry, S | 1 |
| Larsen, MB | 1 |
| Johnstone, HS | 1 |
| Chou, P | 1 |
| Luck, SR | 1 |
| Hammer, M | 1 |
| Cohn, SL | 1 |
| Pranzatelli, MR | 2 |
| Huang, Y | 1 |
| Tate, E | 2 |
| Stanley, M | 1 |
| Noetzel, MJ | 1 |
| Gospe, SM | 1 |
| Banasiak, K | 1 |
| Huang, YY | 1 |
| Goldstein, DS | 1 |
| Holmes, CS | 1 |
| Goldstein, EM | 1 |
| Ketner, K | 1 |
| Kinast, M | 1 |
| Lange, BM | 1 |
| Sanz, A | 1 |
| Shevell, MI | 1 |
| Stanford, RE | 1 |
| Taff, IP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cerebral Autoregulation in Patients With Aneurysmal SubArachnoid Haemorrhage[NCT03987139] | 45 participants (Anticipated) | Interventional | 2019-06-15 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for homovanillic acid and Brown Tendon Sheath Syndrome
| Article | Year |
|---|---|
Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Ataxia; Biomarkers; Child | 1994 |
Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Chromatography, High Pressure Liquid; Electrochemi | 1995 |
4 other studies available for homovanillic acid and Brown Tendon Sheath Syndrome
| Article | Year |
|---|---|
Opsoclonus associated with salmonellosis in a 6-week-old infant.
Topics: Electroencephalography; Homovanillic Acid; Humans; Infant; Male; Ocular Motility Disorders; Salmonel | 2014 |
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.
Topics: Brain; Cell Line, Transformed; Child; Child, Preschool; Cohort Studies; Dopamine Plasma Membrane Tra | 2011 |
Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF.
Topics: Dopamine; Dystonic Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, N | 2004 |
Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Catecholamines; Child, Preschool; Dihyd | 1998 |